Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Helicobacter Pylori | Research

The Associations between Helicobacter Pylori immunoglobulin G seropositivity and body mass index in adults

Authors: Jinke Huang, Kunli Zhang, Fengyun Wang, Xudong Tang

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Objectives

Inconsistent evidence currently exists regarding the associations between Helicobacter Pylori (H. pylori) infection and body mass index (BMI). The goal of the current study was to examine independent associations of H. pylori immunoglobulin G (IgG) seropositivity and BMI in a U.S.-based population sample.

Methods

The US National Health and Nutrition Examination Survey (NHANES) with 2,576 subjects from 1999 to 2000 were analyzed. Using multivariate logistic regression models, associations between H. pylori IgG seropositivity and BMI were calculated after potential confounders were taken into account. Subgroup analyses were conducted furtherly stratified by sex, age, and race.

Results

H. pylori IgG seropositivity was not associated with BMI in the general population (OR = 0.998; 95% CI = 0.977–1.019; P = 0.842). In the subgroup analyses stratified by race, a negative correction was found between the H. pylori IgG seropositivity and BMI among other races (OR = 0.873; 95% CI = 0.795–0.959; P = 0.004) except non-Hispanic white (OR = 1.006, 95% CI 0.966 to 1.048, P = 0.762), non-Hispanic black (OR = 1.021, 95% CI 0.979 to 1.065, P = 0.335), and Mexican American (OR = 1.010, 95% CI 0.966 to 1.055, P = 0.665).

Conclusions

In the general population, H. pylori IgG seropositivity is not associated with increased BMI, which provides a new perspective on obesity management.
Literature
1.
go back to reference Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868–76.CrossRefPubMed Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868–76.CrossRefPubMed
2.
go back to reference Burucoa C, Axon A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2017;22(Suppl 1):1–5. Burucoa C, Axon A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2017;22(Suppl 1):1–5.
3.
go back to reference Santos Maria Luísa Cordeiro, de Brito Breno Bittencourt, da Silva Filipe Antônio França. Helicobacter pylori infection: beyond gastric manifestations. World J Gastroenterol. 2020;26:4076–93. Santos Maria Luísa Cordeiro, de Brito Breno Bittencourt, da Silva Filipe Antônio França. Helicobacter pylori infection: beyond gastric manifestations. World J Gastroenterol. 2020;26:4076–93.
4.
go back to reference Zukiewicz-Sobczak W, et al. Obesity and poverty paradox in developed countries. Ann Agric Environ Med. 2014;21:590–4.CrossRefPubMed Zukiewicz-Sobczak W, et al. Obesity and poverty paradox in developed countries. Ann Agric Environ Med. 2014;21:590–4.CrossRefPubMed
5.
go back to reference Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.CrossRefPubMed Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.CrossRefPubMed
6.
go back to reference Xu Xinlan L, Weide Q, Lan, et al. Relationship between Helicobacter pylori infection and obesity in chinese adults: a systematic review with meta-analysis. PLoS ONE. 2019;14:e0221076.CrossRefPubMedPubMedCentral Xu Xinlan L, Weide Q, Lan, et al. Relationship between Helicobacter pylori infection and obesity in chinese adults: a systematic review with meta-analysis. PLoS ONE. 2019;14:e0221076.CrossRefPubMedPubMedCentral
7.
go back to reference Hamada Masakazu, Nomura Ryota, Ogaya Yuko. Potential involvement of Helicobacter pylori from oral specimens in overweight body-mass index. Sci Rep. 2019;9:4845. Hamada Masakazu, Nomura Ryota, Ogaya Yuko. Potential involvement of Helicobacter pylori from oral specimens in overweight body-mass index. Sci Rep. 2019;9:4845.
8.
go back to reference Xu C, Ming Y, Sun Y et al. Prevalence of Helicobacter pylori infection and its relation with body Mass Index in a Chinese Population. Helicobacter, 2014, 19(6). Xu C, Ming Y, Sun Y et al. Prevalence of Helicobacter pylori infection and its relation with body Mass Index in a Chinese Population. Helicobacter, 2014, 19(6).
9.
go back to reference Kyriazanos ID, Sfiniadakis I, Gizaris V, et al. The incidence of Helicobacter pylori infection is not increased among obese young individuals in Greece. J Clin Gastroenterol. 2002;34(5):541.CrossRefPubMed Kyriazanos ID, Sfiniadakis I, Gizaris V, et al. The incidence of Helicobacter pylori infection is not increased among obese young individuals in Greece. J Clin Gastroenterol. 2002;34(5):541.CrossRefPubMed
10.
go back to reference Ioannou GN, Weiss NS, Kearney DJ. Is Helicobacter pylori seropositivity related to body mass index in the United States?Aliment. Pharmacol Ther. 2005;21:765–72. Ioannou GN, Weiss NS, Kearney DJ. Is Helicobacter pylori seropositivity related to body mass index in the United States?Aliment. Pharmacol Ther. 2005;21:765–72.
11.
go back to reference Pundak OY, Olivestone CT, Hofi L et al. Lack of association between Helicobacter pylori infection and childhood overweight/obesity. Helicobacter, 2020, 25(5). Pundak OY, Olivestone CT, Hofi L et al. Lack of association between Helicobacter pylori infection and childhood overweight/obesity. Helicobacter, 2020, 25(5).
12.
go back to reference Murray CD, Kamm MA, Bloom SR, Emmanuel AV. Ghrelin for the gastroenterologist: history and potential. Gastroenterology. 2003;125:1492–502.CrossRefPubMed Murray CD, Kamm MA, Bloom SR, Emmanuel AV. Ghrelin for the gastroenterologist: history and potential. Gastroenterology. 2003;125:1492–502.CrossRefPubMed
13.
go back to reference Breidert M, Miehlke S, Glasow A, et al. Leptin and its receptor in normal human gastric mucosa and in Helicobacter pyloriassociated gastritis. Scand J Gastroenterol. 1999;34:954–61.CrossRefPubMed Breidert M, Miehlke S, Glasow A, et al. Leptin and its receptor in normal human gastric mucosa and in Helicobacter pyloriassociated gastritis. Scand J Gastroenterol. 1999;34:954–61.CrossRefPubMed
14.
go back to reference Dillon CF, Weisman MH. US National Health and Nutrition Examination Survey Arthritis Initiatives, Methodologies and Data. Rheumatic Dis Clin North Am. 2018;44(2):215–65.CrossRef Dillon CF, Weisman MH. US National Health and Nutrition Examination Survey Arthritis Initiatives, Methodologies and Data. Rheumatic Dis Clin North Am. 2018;44(2):215–65.CrossRef
15.
go back to reference CDC. Helicobacter pylori ELISA measurement in NHANES. 2008. Accessed Jan 1st, 2020. CDC. Helicobacter pylori ELISA measurement in NHANES. 2008. Accessed Jan 1st, 2020.
16.
go back to reference Kantor ED et al. “Trends in Dietary supplement use among US adults from 1999–2012.” JAMA vol. 316,14 (2016): 1464–74. Kantor ED et al. “Trends in Dietary supplement use among US adults from 1999–2012.” JAMA vol. 316,14 (2016): 1464–74.
17.
go back to reference Renshaw AA, Rabaza JR, Gonzalez AM, Verdeja JC. Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity. Obes Surg. 2001;11:281–3.CrossRefPubMed Renshaw AA, Rabaza JR, Gonzalez AM, Verdeja JC. Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity. Obes Surg. 2001;11:281–3.CrossRefPubMed
18.
go back to reference Wu MS, Lee WJ, Wang HH, Huang SP, Lin JT. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med. 2005;165:1552–5.CrossRefPubMed Wu MS, Lee WJ, Wang HH, Huang SP, Lin JT. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med. 2005;165:1552–5.CrossRefPubMed
19.
go back to reference Yang YJ, Sheu BS, Chang WL, Cheng HC, Yang HB. Increased body mass index after H. pylori eradication for duodenal ulcer predisposes to erosive reflux esophagitis. J Clin Gastroenterol. 2009;43:705–10.CrossRefPubMed Yang YJ, Sheu BS, Chang WL, Cheng HC, Yang HB. Increased body mass index after H. pylori eradication for duodenal ulcer predisposes to erosive reflux esophagitis. J Clin Gastroenterol. 2009;43:705–10.CrossRefPubMed
20.
go back to reference Abdullahi M, Annibale B, Capoccia D, Tari R, Lahner E, Osborn J, et al. The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg. 2008;18:1450–4.CrossRefPubMed Abdullahi M, Annibale B, Capoccia D, Tari R, Lahner E, Osborn J, et al. The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg. 2008;18:1450–4.CrossRefPubMed
21.
go back to reference Arslan E, Atilgan H, Yavasoglu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med. 2009;20:695–7.CrossRefPubMed Arslan E, Atilgan H, Yavasoglu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med. 2009;20:695–7.CrossRefPubMed
22.
go back to reference Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:922–9.CrossRefPubMed Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:922–9.CrossRefPubMed
23.
go back to reference Palmblad J, Hallberg D, Engstedt L. Polymorphonuclear (PMN) function after small intestinal shunt operation for morbid obesity. Br J Haematol. 1980;44:101–8.CrossRefPubMed Palmblad J, Hallberg D, Engstedt L. Polymorphonuclear (PMN) function after small intestinal shunt operation for morbid obesity. Br J Haematol. 1980;44:101–8.CrossRefPubMed
24.
go back to reference Krishnan EC, Trost L, Aarons S, Jewell WR. Study of function and maturation of monocytes in morbidly obese individuals. J Surg Res. 1982;33:89–97.CrossRefPubMed Krishnan EC, Trost L, Aarons S, Jewell WR. Study of function and maturation of monocytes in morbidly obese individuals. J Surg Res. 1982;33:89–97.CrossRefPubMed
25.
go back to reference Moulin CM, Marguti I, Peron JP, Rizzo LV, Halpern A. Impact of adiposity on immunological parameters. Arq Bras Endocrinol Metabol. 2009;53:183–9.CrossRefPubMed Moulin CM, Marguti I, Peron JP, Rizzo LV, Halpern A. Impact of adiposity on immunological parameters. Arq Bras Endocrinol Metabol. 2009;53:183–9.CrossRefPubMed
26.
go back to reference Basso D, Plebani M, Kusters JG. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2010;15(Suppl 1):14–20.CrossRefPubMed Basso D, Plebani M, Kusters JG. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2010;15(Suppl 1):14–20.CrossRefPubMed
Metadata
Title
The Associations between Helicobacter Pylori immunoglobulin G seropositivity and body mass index in adults
Authors
Jinke Huang
Kunli Zhang
Fengyun Wang
Xudong Tang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08427-1

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine